Trials / Completed
CompletedNCT04812951
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in Post Surgical Ocular Surface System Failure Within The Age
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Campus Bio-Medico University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Use of Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in cataract Surgery
Detailed description
To asses ocular discomfort symptoms and signs and inflammatory biomarkers after preoperative topical cyclosporine 0.1% eye drops therapy in high risk elder population after a specific insult such as cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion | one cyclosporine 0.1% eye drop twice a day for 30 preoperative days |
| DEVICE | cationorm eye drops | one cationorm eye drop twice a day for 30 preoperative days |
Timeline
- Start date
- 2021-02-17
- Primary completion
- 2021-06-18
- Completion
- 2022-02-23
- First posted
- 2021-03-24
- Last updated
- 2023-02-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04812951. Inclusion in this directory is not an endorsement.